C-BIGR is the world’s only Open Science biobank and patient registry—home to over 3,000 patient contributions, 120+ cell lines, and CRISPR-repaired controls. It fuels global collaboration in neuroscience research, supporting precision trials in ALS, MS, Parkinson’s, and more.

Researchers can access clinical data, neuropsychiatric testing, imaging, and genetics—fully traceable and openly accessible.

ISBER attendees will be touring C-BIGR on-site this Monday afternoon—a unique look into one of the most innovative biobanks in the world. To learn more about C-BIGR and the full Specimen Center network, stop by the AminoChain booth (#24) at ISBER.